Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIA-2291 in carotid stenosis patients undergoing carotid endarterectomy
2006-001635-21Phase 2Completed
- Sponsor
- VIA Pharmaceuticals, Inc.
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in carotid atheroma (CAS) and atherosclerosis comparing Atreleuton with Placebo (2 arms). Primary endpoints: Ex vivo plaque leukotriene B4 concentration and Change from baseline in ex vivo whole-blood leukotriene B4 synthesis. Started Jan 2007; status: completed.
02
Drugs
Atreleuton
03
Conditions
carotid atheroma (CAS)atherosclerosis
Beyond the preview
Go deeper on 2006-001635-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001635-21.